Preclinical Pharmacokinetic Studies of a Novel Diuretic Inhibiting Urea Transporters

Urea transporter (UT) inhibitors are a class of promising novel diuretics that do not cause the imbalance of Na⁺, K⁺, Cl⁻, and other electrolytes. In our previous studies, 25a, a promising diuretic candidate inhibiting UT, was discovered and showed potent diuretic activities in rodents. Here, a sensitive liquid chromatography–tandem mass spectrometry method for the quantitation of 25a in rat plasma, urine, feces, bile, and tissue homogenates was developed and validated to support the preclinical pharmacokinetic studies. The tissue distribution, excretion, and plasma protein binding were investigated in rats. After a single oral dose of 25a at 25, 50, and 100 mg/kg, the drug exposure increased linearly with the dose. The drug accumulation was observed after multiple oral doses compared to a single dose. In the distribution study, 25a exhibited a wide distribution to tissues with high blood perfusion, such as kidney, heart, lung, and spleen, and the lowest distribution in the brain and testis. The accumulative excretion rate of 25a was 0.14%, 3.16%, and 0.018% in urine, feces, and bile, respectively. The plasma protein binding of 25a was approximately 60% in rats and 40% in humans. This is the first study on the preclinical pharmacokinetic profiles of 25a.     

Determination of diuretics in human urine using HPLC coupled with magnetic solid-phase extraction based on a metal–organic framework

Magnetic solid-phase extraction (MSPE) employing a metal–organic framework (Fe₃O₄@UiO-66-OH) combined with high-performance liquid chromatography was developed for the determination of trace diuretics in urine. The structure and properties of Fe₃O₄@UiO-66-OH were investigated using X-ray diffraction, infrared spectroscopy, scanning electron microscopy and vibrating sample magnetometry. Magnetic solid-phase extraction conditions, such as adsorbent amount and solution pH, were optimized using response surface methodology. Under the optimal conditions, the method resulted in excellent linearity with a high correlation coefficient (r > 0.99), satisfactory intraday repeatability (1.78–2.99%), low limits of detection (0.08–0.23 ng/ml), and good recoveries in urine samples (between 93.5 and 103%). Fe₃O₄@UiO-66-OH based on MSPE is a novel pretreatment technique for the detection of trace diuretics in urine.     

毛细管电泳-柱端喷壁式电化学检测法用于利尿剂氢氯噻嗪和氨苯喋啶的研究

应用毛细管电泳-电化学检测法对利尿剂氢氯噻嗪和氨苯喋啶进行了研究。考察了电化学检测和电泳分离条件对氢氯噻嗪和氨苯喋啶分离、检测的影响,结果表明在最佳分离、检测条件下,两种待测物在8 min内达到基线分离。氨苯喋啶和氢氯噻嗪的检测限分别达到0.29和0.25 mg/L。对两物质于日内和日间重复测定7次,迁移时间的日内相对标准偏差(RSD)不大于1.6％,峰电流的日内RSD不大于 3.1％; 迁移时间的日间RSD不大于1.7％,峰电流的日间RSD不大于 4.9％。 将该方法用于复方氨苯喋啶成药中氨苯喋啶和氢氯噻嗪的分离和测定,成药的检测结果与标示量比较,相对误差小于4.6％。在模拟尿样中对氢氯噻嗪和氨苯喋啶进行标准溶液添加回收实验,其回收率分别为93.5%~96.7%和96.6%~97.2%,结果令人满意。